RecruitingNCT07198152

Artificial Intelligence Used in Screening Adrenal Nodules

The Application of Artificial Intelligence in Screening Adrenal Nodules in Low-dose Chest CT


Sponsor

Peking University First Hospital

Enrollment

600 participants

Start Date

Sep 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

By collecting chest low-dose spiral CT plain scan images, extracting effective features from the adrenal gland regions, training and validating an artificial intelligence-based automatic diagnostic algorithm for adrenal nodules, we will ultimately develop an artificial intelligence software with independent intellectual property rights that is specifically designed for screening adrenal nodules in chest low-dose CT scans.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • The age of the population is over 18 years old, regardless of gender;
  • Images from chest low-dose CT plain scan during routine physical examination;

Exclusion Criteria2

  • Patients with a history of malignant tumors;
  • Imaging images with poor quality, artifacts, etc., which make analysis impossible.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNone intervention

this study is retrospective based on the CT images, which dose include any intervention.


Locations(1)

Peking University First Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07198152


Related Trials